Generic Name and Formulations:
Crofelemer 125mg; delayed-release tablets; enteric-coated.
Napo Pharmaceuticals, Inc.
Indications for MYTESI:
Symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy.
Swallow whole. One tab twice daily.
<18yrs: not established.
Rule out infectious etiologies of diarrhea before starting. Pregnancy (Cat. C). Nursing mothers: not recommended.
Upper respiratory tract infection, bronchitis, cough, flatulence, increased bilirubin.
Formerly known under the brand name Fulyzaq.